ABG Innovation Capital Partners III GP Ltd Long-Term Concentrated

CIK: 0001845297 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $1,463 (100.0% shares, 0.0% debt)

Holdings (5)

— SYNLOGIC INC 33.8%

Value ($000) $494 Shares 205,906 Est. Cost $2.16 Unrealized —

GNCAQ GENOCEA BIOSCIENCES INC 32.1%

Value ($000) $469 Shares 375,000 Est. Cost $2.28 Unrealized -52.2%

WHWK AADI BIOSCIENCES INC 31.0%

Value ($000) $453 Shares 26,666 Est. Cost $30.48 Unrealized -37.1%

— IDERA PHARMACEUTICALS INC 1.9%

Value ($000) $28 Shares 56,250 Est. Cost $3.66 Unrealized —

— NABRIVA THERAPEUTICS PLC 1.3%

Value ($000) $19 Shares 45,849 Est. Cost $2.42 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SYNLOGIC INC	205,906	$494	33.8%	$2.16	—	COM	87166L100
GNCAQ	GENOCEA BIOSCIENCES INC	375,000	$469	32.1%	$2.28	-52.2%	COM NEW	372427401
WHWK	AADI BIOSCIENCES INC	26,666	$453	31.0%	$30.48	-37.1%	COM	00032Q104
—	IDERA PHARMACEUTICALS INC	56,250	$28	1.9%	$3.66	—	COM PAR	45168K405
—	NABRIVA THERAPEUTICS PLC	45,849	$19	1.3%	$2.42	—	SHS	G63637113